Gardasil 9 syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FWHW7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $136,589
Award facts
- Contract value 100% obligated
- $136,589.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $136,589.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 0.5mL GARDASIL 9 syringes, with an ultimate completion date of January 27, 2026. This is a non-set-aside competitive award issued on January 26, 2026, with performance to be executed at the awardee's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical program, valued at up to $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that supplies critical medical commodities including vaccines, medications, and medical devices to federal military and veteran healthcare systems. The GARDASIL 9 procurement aligns with the Defense Logistics Agency's medical supply chain objectives to support military treatment facilities and Defense Health Agency operations globally. The firm fixed-price structure and competitive award reflect the contractor's demonstrated capability to efficiently fulfill federal pharmaceutical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FWHW7?
SPE2DR26FWHW7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FWHW7 worth?
The government has obligated $136,589 on SPE2DR26FWHW7.
Is contract SPE2DR26FWHW7 an order under another contract?
Yes. SPE2DR26FWHW7 is a delivery order under SPE2DR25D3009, an indefinite delivery contract.
Was contract SPE2DR26FWHW7 competed?
The extent of competition for SPE2DR26FWHW7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award